These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3607752

  • 21. Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo.
    Versluis AJ, Rump ET, Rensen PC, van Berkel TJ, Bijsterbosch MK.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):1-7. PubMed ID: 10086980
    [Abstract] [Full Text] [Related]

  • 22. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents.
    Glickson JD, Lund-Katz S, Zhou R, Choi H, Chen IW, Li H, Corbin I, Popov AV, Cao W, Song L, Qi C, Marotta D, Nelson DS, Chen J, Chance B, Zheng G.
    Mol Imaging; 2008 Apr; 7(2):101-10. PubMed ID: 18706292
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparative study of the incorporation of ellipticine-esters into low density lipoprotein (LDL) and selective cell uptake of drug--LDL complex via the LDL receptor pathway in vitro.
    Samadi-Baboli M, Favre G, Bernadou J, Berg D, Soula G.
    Biochem Pharmacol; 1990 Jul 15; 40(2):203-12. PubMed ID: 2375762
    [Abstract] [Full Text] [Related]

  • 27. LDL receptor-dependent polyunsaturated fatty acid transport and metabolism.
    Habenicht AJ, Salbach P, Janssen-Timmen U.
    Eicosanoids; 1992 Jul 15; 5 Suppl():S29-31. PubMed ID: 1449825
    [Abstract] [Full Text] [Related]

  • 28. Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo.
    Vitols S, Peterson C, Larsson O, Holm P, Aberg B.
    Cancer Res; 1992 Nov 15; 52(22):6244-7. PubMed ID: 1423268
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Low density lipoprotein as a carrier of cytostatics in cancer chemotherapy: study of stability of drug-carrier complexes in blood.
    Masquelier M, Vitols S, Pålsson M, Mårs U, Larsson BS, Peterson CO.
    J Drug Target; 2000 Nov 15; 8(3):155-64. PubMed ID: 10938525
    [Abstract] [Full Text] [Related]

  • 31. A novel fluorescence method to monitor the lysosomal disintegration of low density lipoprotein.
    Ohashi M, Murata M, Ohnishi S.
    Eur J Cell Biol; 1992 Oct 15; 59(1):116-26. PubMed ID: 1468435
    [Abstract] [Full Text] [Related]

  • 32. Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells.
    Kader A, Pater A.
    J Control Release; 2002 Apr 23; 80(1-3):29-44. PubMed ID: 11943385
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Osmotic cell swelling stimulates receptor-mediated low density lipoprotein endocytosis and degradation.
    Greer MA, Hagemenas FC, Illingworth DR.
    Horm Metab Res; 1992 Sep 23; 24(9):454. PubMed ID: 1427621
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.